Free Trial

Adaptive Biotechnologies (ADPT) News Today

Adaptive Biotechnologies logo
$8.93 +0.09 (+1.02%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$8.99 +0.06 (+0.68%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADPT Latest News

Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Bought by Point72 Asset Management L.P.
Point72 Asset Management L.P. increased its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 89.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 937,331 shares of
Adaptive Biotechnologies Co. stock logo
Deutsche Bank AG Grows Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Deutsche Bank AG boosted its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 397.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 630,577 shares of the company's stock after buying an additional 503,842 shares during the
Adaptive Biotechnologies Co. stock logo
Northern Trust Corp Acquires 130,449 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Northern Trust Corp increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 13.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,093,981 shares of the company's stock after acquirin
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Soleus Capital Management L.P.
Soleus Capital Management L.P. increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 168.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,983,142 shares of the company's stock after purchasing an a
Adaptive Biotechnologies Co. stock logo
40,914 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by Graham Capital Management L.P.
Graham Capital Management L.P. purchased a new stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 40,914 shares of the company's stock, v
Adaptive Biotechnologies Co. stock logo
Millennium Management LLC Has $37.72 Million Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Millennium Management LLC cut its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 33.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,292,634 shares of the company's stock after selling 3,10
Adaptive Biotechnologies Co. stock logo
53,170 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Bought by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. purchased a new position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 53,170 shares of the company's stock, v
Adaptive Biotechnologies Co. stock logo
Jane Street Group LLC Sells 97,690 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Jane Street Group LLC lessened its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 19.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 406,587 shares of the company's stock after sell
Adaptive Biotechnologies Co. stock logo
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 29.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 213,829 sh
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Holdings Lowered by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD reduced its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 41.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,892 shares
Adaptive Biotechnologies Co. stock logo
Driehaus Capital Management LLC Buys 410,877 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Driehaus Capital Management LLC grew its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 94.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 846,171 shares of the company's stock after pur
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP raised its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 12.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,604,876 shares of the company's stock after buying an additiona
Adaptive Biotechnologies Co. stock logo
Algert Global LLC Boosts Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Algert Global LLC raised its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 464.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 430,514 shares of the company's sto
Adaptive Biotechnologies Co. stock logo
Caxton Associates LP Buys New Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Caxton Associates LP purchased a new position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 123,287 shares of the company's stoc
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Insider Harlan S. Robins Sells 68,412 Shares
Adaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) insider Harlan S. Robins sold 68,412 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $7.35, for a total value of $502,828.20. Following the sale, the insider now owns 1,279,524 shares in the company, valued at $9,404,501.40. The trade was a 5.08 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Consensus Rating of "Moderate Buy" by Analysts
Adaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume on Analyst Upgrade
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Large Volume Increase Following Analyst Upgrade
Adaptive Biotechnologies Co. stock logo
Morgan Stanley Issues Positive Forecast for Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price
Morgan Stanley increased their price objective on Adaptive Biotechnologies from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research note on Monday.
Adaptive Biotechnologies Co. stock logo
37,759 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by Susquehanna Fundamental Investments LLC
Susquehanna Fundamental Investments LLC bought a new stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 37,759 shares of the company's stock, value
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies (NASDAQ:ADPT) Issues Earnings Results
Adaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.28) by $0.08. The business had revenue of $52.44 million during the quarter, compared to the consensus estimate of $42.13 million. Adaptive Biotechnologies had a negative return on equity of 64.65% and a negative net margin of 89.12%. The company's quarterly revenue was up 25.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.33) earnings per share.
Adaptive Biotechnologies Co. stock logo
Aristotle Atlantic Partners LLC Sells 114,499 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Aristotle Atlantic Partners LLC reduced its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 3.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,886,702 shares of the company's st
Adaptive Biotechnologies Co. stock logo
Tudor Investment Corp ET AL Sells 57,284 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Tudor Investment Corp ET AL trimmed its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 11.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 458,488 shares of the company's sto
Adaptive Biotechnologies Co. stock logo
Barclays PLC Grows Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Barclays PLC lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 15.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 266,066 shares of the company's stock after acquiring an additional 35,889 shares during th
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month High Following Better-Than-Expected Earnings
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High Following Earnings Beat
Adaptive Biotechnologies Co. stock logo
PDT Partners LLC Increases Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
PDT Partners LLC boosted its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 12.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 316,281 shares of the company's stock after acquiring an additional 35,899 shares during the per
Adaptive Biotechnologies Co. stock logo
51,694 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Bought by Dark Forest Capital Management LP
Dark Forest Capital Management LP acquired a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 51,694 shares of the company'
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Voya Investment Management LLC
Voya Investment Management LLC lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 6,121.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,428,710 shares of the company's stock after acqu
Adaptive Biotechnologies Co. stock logo
Renaissance Technologies LLC Buys 60,385 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Renaissance Technologies LLC boosted its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 35.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 229,785 shares of the company's stock after acquiri
Adaptive Biotechnologies Co. stock logo
Legal & General Group Plc Buys 97,798 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Legal & General Group Plc boosted its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 902.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,630 shares of the company's stock afte
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies (ADPT) Expected to Announce Quarterly Earnings on Thursday
Adaptive Biotechnologies (NASDAQ:ADPT) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-adaptive-biotechnologies-co-stock/)
Adaptive Biotechnologies Co. stock logo
JPMorgan Chase & Co. Lowers Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
JPMorgan Chase & Co. cut its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 25.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 659,206 shares of the company's stock after
Adaptive Biotechnologies Co. stock logo
Franklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Franklin Resources Inc. bought a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 73,844 shares of the company's stock, valued at appro
Adaptive Biotechnologies Co. stock logo
Cerity Partners LLC Reduces Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Cerity Partners LLC reduced its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 31.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 478,448 shares of the company's stock aft
Adaptive Biotechnologies Co. stock logo
Pictet Asset Management Holding SA Trims Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Pictet Asset Management Holding SA lessened its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 97.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,937 shares of the company's stock a
Adaptive Biotechnologies Co. stock logo
Vanguard Group Inc. Has $64.24 Million Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Vanguard Group Inc. grew its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 10,714,888 shares of the company's stock after acquiring an additional 75,448 shares during th
Adaptive Biotechnologies Co. stock logo
Trexquant Investment LP Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
Trexquant Investment LP acquired a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 185,868 shares of the company's stock, valued at approximatel
Adaptive Biotechnologies Co. stock logo
ExodusPoint Capital Management LP Takes $1.48 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
ExodusPoint Capital Management LP purchased a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 246,865 shares of the company's stock, valued at approximatel
Adaptive Biotechnologies Co. stock logo
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 9.4% - Here's What Happened
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 9.4% Higher - Time to Buy?
Get Adaptive Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter.

ADPT Media Mentions By Week

ADPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADPT
News Sentiment

1.52

0.75

Average
Medical
News Sentiment

ADPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADPT Articles
This Week

9

4

ADPT Articles
Average Week

Get Adaptive Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ADPT) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners